Post Marketing Surveillance Study of Biphasic Insulin Aspart 30
NCT01536613
·
clinicaltrials.gov ↗
COMPLETED
Status
5346
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Interventions
DRUG:
biphasic insulin aspart 30
Sponsor
Novo Nordisk A/S